Rhythm Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-23.2M | $-24.3M | $1.1M | $1.2M |
| FY2017 | $-29.5M | $-29.6M | $133.0K | $2.3M |
| FY2018 | $-62.1M | $-62.8M | $722.0K | $6.4M |
| FY2019 | $-122.8M | $-126.1M | $3.4M | $11.9M |
| FY2020 | $-122.0M | $-122.2M | $214.0K | $17.5M |
| FY2021 | $-146.0M | $-146.4M | $434.0K | $20.8M |
| FY2022 | $-173.4M | $-173.7M | $281.0K | $19.8M |
| FY2023 | $-136.2M | $-136.2M | $47.0K | $32.6M |
| FY2024 | $-113.9M | $-113.9M | $0 | $39.7M |
| FY2025 | $-115.7M | $-116.6M | $953.0K | $66.8M |